CHU Timone
CHU Timone
Marseille, France5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mixed phenotype acute leukemia, neoplasm | Recruiting | Phase 3 | 2026-07-10 | NCT05327894 | |
| Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up | Head and Neck Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Phase 3 | 2026-06-25 | NCT04290663 | |
| Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01) | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 2 | 2026-01-13 | NCT07337447 | |
| Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. | Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma | Recruiting | Phase 2 | 2025-12-19 | NCT07192068 | |
| Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging | Alzheimer disease, Brain Concussion, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Concussion, Mild, Craniocerebral Trauma, Epileptic Syndromes, Head Injuries, Closed, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, Wounds, Nonpenetrating, acute transverse myelitis, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, brain injury, central nervous system disorder, cognitive disorder, cranial nerve neuropathy, dementia, demyelinating disease, epilepsy, eye disorder, focal epilepsy, immune system disorder, injury, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, neuromyelitis optica, optic nerve disorder, optic neuritis, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy, temporal lobe epilepsy | Recruiting | Not stated | 2025-10-01 | NCT07202494 |